In the light of the known links between integrins and Fak/Src signalling in both normal and cancer cells (Mitra & Schlaepfer, 2006) and the effects that we have found for Src and Fak downstream of Ret activation, Ret could provide a new route for the integrin activation of the Src/Fak complex. Here, PTK2 is linked to cancer.